{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T20:27:32Z","timestamp":1772137652124,"version":"3.50.1"},"reference-count":13,"publisher":"Informa UK Limited","issue":"7","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Clinical Toxicology"],"published-print":{"date-parts":[[2021,7,3]]},"DOI":"10.1080\/15563650.2020.1842882","type":"journal-article","created":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T05:03:07Z","timestamp":1614574987000},"page":"644-647","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":10,"title":["Safety and effectiveness concerns of lopinavir\/ritonavir in COVID-19 affected patients: a retrospective series"],"prefix":"10.1080","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7518-185X","authenticated-orcid":false,"given":"Marc-Antoine","family":"Lepage","sequence":"first","affiliation":[{"name":"McGill University Health Centre, Montreal, Canada"},{"name":"McGill Faculty of Medecine and Health Sciences, Montreal, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Rozza","sequence":"additional","affiliation":[{"name":"McGill Faculty of Medecine and Health Sciences, Montreal, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7053-2139","authenticated-orcid":false,"given":"Richard","family":"Kremer","sequence":"additional","affiliation":[{"name":"McGill University Health Centre, Montreal, Canada"},{"name":"McGill Faculty of Medecine and Health Sciences, Montreal, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8745-0036","authenticated-orcid":false,"given":"Ami","family":"Grunbaum","sequence":"additional","affiliation":[{"name":"McGill University Health Centre, Montreal, Canada"},{"name":"McGill Faculty of Medecine and Health Sciences, Montreal, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2021,3,1]]},"reference":[{"key":"CIT0001","unstructured":"AbbVie Corporation. Product Monograph. Kaletra. Lopinavir\/ritonavir [cited 2019, Sept 27]. Available from: https:\/\/www.abbvie.ca\/content\/dam\/abbvie-dotcom\/ca\/en\/documents\/products\/KALETRA_PM_EN.pdf."},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dki314"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-200308150-00007"},{"key":"CIT0004","unstructured":"Phillips A. Important Safety Information Regarding a Drug Interaction Between Fluticasone Propionate (Flonase\/Flovent\/Advair) and Ritonavir (Norvir\/Kaletra). Health Canada; 2004."},{"key":"CIT0005","unstructured":"Bayer HealthCare Pharmaceuticals Inc. Betapace (sotalol HCl) 2010. [cited 2019, Sept 27]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2011\/019865s019lbl.pdf."},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.7326\/M20-1550"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkaa195"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2008.302"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2001282"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2020.104786"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.112.044677"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200241140-00002"},{"key":"CIT0013","unstructured":"World Health Organization. \u201cSolidarity\u201d clinical trial for COVID-19 treatments 2020. [cited 2020, July 7]. Available from: https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/global-research-on-novel-coronavirus-2019-ncov\/solidarity-clinical-trial-for-covid-19-treatments."}],"container-title":["Clinical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/15563650.2020.1842882","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,14]],"date-time":"2021-07-14T05:09:34Z","timestamp":1626239374000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/15563650.2020.1842882"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,1]]},"references-count":13,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7,3]]}},"alternative-id":["10.1080\/15563650.2020.1842882"],"URL":"https:\/\/doi.org\/10.1080\/15563650.2020.1842882","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.07.23.20153932","asserted-by":"object"}]},"ISSN":["1556-3650","1556-9519"],"issn-type":[{"value":"1556-3650","type":"print"},{"value":"1556-9519","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,1]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ictx20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ictx20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-08-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-10-19","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-10-20","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}